A. M. Forster

The Retention Mechanism of Technetium-99m-HM-PAO: Intracellular Reaction with Glutathione

N. Lassen, A. Andersen, N A Lassen, 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.

M. Mcpartlin, A. M. Forster, C. M. Archer, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Fluorination of dimethyl sulphide. Formation of the fluorodimethylsulphonium cation, [Me2SF]+, and dimethylsulphur difluoride, Me2SF2

A. J. Downs, A. M. Forster, 1984 .

FLUORINATION OF DIMETHYL SULFIDE. FORMATION OF THE FLUORODIMETHYLSULFONIUM CATION, (ME2SF)+, AND DIMETHYLSULFUR DIFLUORIDE, ME2SF2

A. J. Downs, A. M. Forster, 1985 .

Reactions of xenon difluoride: Oxidative fluorination of methyl derivatives of the p-block elements

A. J. Downs, A. M. Forster, 1985 .

Synthesis, physical characterisation and chemical properties of methylsulphur trifluoride, CH3SF3

A. J. Downs, G. Mcgrady, A. M. Forster, 1991 .

Technetium-99 m d , l-HM-PAO : A New Rathopharmaceutical for SPECT Imaging of Regional CerebralBlood Perfusion

R A Holmes, W A Volkert, R. A. Holmes, 2006 .

Equilibration of ortho- and para-hydrogen by homogeneous hydrogenation catalysts in solution; A test for the reversibility of hydrogen addition using Raman spectroscopy

A. J. Downs, John M. Brown, A. M. Forster, 1983 .

A method for stabilising technetium-99m exametazime prepared from a commercial kit

A. M. Forster, B. Higley, A. E. Storey, 1993, European Journal of Nuclear Medicine.

Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imaging

R. A. Holmes, D. Nowotnik, W. Volkert, 1985, Nuclear medicine communications.

Use of sodium iodide to overcome the eluate age restriction for Ceretec reconstitution.

D. Tyrrell, D A Tyrrell, A. M. Forster, 1989, Nuclear medicine communications.